About Xention

The importance of ion channels in disease pathology is well established, however, due to inadequate discovery technologies, this class of targets has been under-exploited to date. Xention's proprietary ion channel capabilities address this problem and provide the Company with the tools to discover and develop novel and effective drug candidates for important underserved disorders. The Company is thus developing a pipeline of ion channel drug molecules across a number of indications.